Cutaneous Oncology News

Although recipients of all organ types develop additional skin cancer, age at transplant was a greater predictor than organ type for recurring cases, according to a cohort study.

Individuals who undergo skin screenings experience higher rates of biopsies and melanoma, according to a study.

More than half of patients had an objective response to first-line nivolumab for locally advanced or metastatic cutaneous squamous cell carcinoma, phase 2 study results published in Cancer showed.

Immunosuppression is not an independent risk factor for poor outcomes in patients with cutaneous squamous cell carcinomas when adjusting for tumor stage, according to a study.

A novel imaging technique was associated with high sensitivity, specificity and accuracy in diagnosing nonmelanoma skin cancers, according to a study.

GENEVA — Factors such as age and comorbidities appeared associated with longer time to melanoma diagnosis, according to study results presented at World Cancer Congress.

The FDA granted regenerative medicine advanced therapy designation to CTX130, a chimeric antigen receptor T-cell therapy under development for the treatment of mycosis fungoides and Sézary syndrome.

DENVER — Survival of Merkel cell carcinoma can be impacted by primary tumor site, with head and neck tumors showing the highest rates of morbidity, according to a study presented here.

DENVER — Individuals with skin of color are more likely to have pigmented basal cell carcinoma and present with keratinocyte carcinoma at a younger age than white non-Hispanic individuals, according to a study presented here.

DENVER — Ropivacaine duration varies by anatomic region, with the anesthesia lasting shorter amounts of time in highly vascular regions, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.